Abstract 89P
Background
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the nasopharynx that raises public health concern in its endemic region due to its late diagnosis. The preclinical study of NPC and the bench-to-bed transition is challenged by the lack of appropriate NPC models. Conventional two-dimensional (2D) cell culture models fail to accurately replicate the complex three-dimensional (3D) structure and microenvironment of solid tumour while available 3D spheroid models for NPC do not take into account the interaction between different cell types.
Methods
In this study, we aimed to generate 3D multicellular tumour spheroids (MCTSs) to mimic the in vivo tumour architecture and microenvironment. Homotypic MCTSs were generated using Epstein-Barr virus (EBV)-positive (C666-1, NPC43) and EBV-negative NPC (HK-1) cell lines, respectively, while heterotypic MCTSs involve co-culturing EBV-positive and EBV-negative cells with stromal cells including fibroblasts (MRC-5) and HUVEC). Spheroids were constructed using the scaffold-based technique, and morphological examination was performed using light microscopy and fluorescence microscopy to characterize the spheroid size, shape and cellular organization.
Results
Homotypic and heterotypic MCTSs generated from EBV-positive and EBV-negative cell lines form spherical aggregates. H&E staining of the MCTSs demonstrated in vivo tumour characteristics, including 3D organisation, scanted cytoplasm, irregular and enlarged nuclei, and necrotic regions. EBV+ cell lines generally formed homotypic MCTSs with more compact and spherical morphology, while homotypic MCTSs generated from EBV- cell lines are less compact and displayed alveolar-like shape. The presence of NPC cells, fibroblasts, and endothelial cells in the heterotypic MCTSs were confirmed using immunofluorescence staining.
Conclusions
Homotypic and heterotypic MCTSs were generated from both EBV- and EBV+ NPC cells. The MCTSs generated replicates the in vivo tumour features in vitro. This model would serve as a platform for the study of intercellular interactions and evaluation of potential therapeutic responses.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Malaysia Ministry of Higher Education.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
105P - Subsequent treatments after progression on cyclin-dependent kinase 4/6 inhibitors: A multicentric real-world data study
Presenter: Ana Rita Freitas
Session: Cocktail & Poster Display session
Resources:
Abstract
106P - Toxicity profile antibody-drug conjugates (ADCs) in metastatic breast cancer patients: A systematic review and meta-analysis based on studies’ design
Presenter: Silvia Belloni
Session: Cocktail & Poster Display session
Resources:
Abstract
107P - Receptor change on residual disease following neoadjuvant therapies for locally advanced breast cancer fails to impact oncological and survival outcomes
Presenter: Rionagh Lynch
Session: Cocktail & Poster Display session
Resources:
Abstract
114P - Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial
Presenter: Davide Ciardiello
Session: Cocktail & Poster Display session
Resources:
Abstract
115P - Impact of tissue factor on clinical and biological characteristics in patients with advanced pancreatic cancer
Presenter: Taro Shibuki
Session: Cocktail & Poster Display session
Resources:
Abstract
116P - Multiomic profiling based on <italic>Akkermansia muciniphila</italic> in advanced non-small cell lung cancer
Presenter: Lorenzo Belluomini
Session: Cocktail & Poster Display session
Resources:
Abstract
117P - Transforming public patient omic data into precision oncology targets: A comprehensive pan-cancer approach
Presenter: Eléonore Fox
Session: Cocktail & Poster Display session
Resources:
Abstract
118P - Whole transcriptome sequencing of lung tissue to combine disease classification and identification of actionable targets
Presenter: Alejandro Pallares Robles
Session: Cocktail & Poster Display session
Resources:
Abstract
119P - Genetic profiling of breast cancer in a developing country: Towards the establishment of oncogenetics in Cameroon
Presenter: Kenn Chi Ndi
Session: Cocktail & Poster Display session
Resources:
Abstract
120P - Uncovering the prognostic potential of FGFR2c isoform expression in advanced gastroesophageal cancer through MONSTAR-SCREEN-2 analysis
Presenter: Tadayoshi Hashimoto
Session: Cocktail & Poster Display session
Resources:
Abstract